About DePuy Synthes Companies

  • Contact Us
  • Healthcare Providers
  • Patients & Caregivers

Search DePuy Synthes


News and Press

Our Latest News


Johnson & Johnson Medical Devices Companies Value-Based Solutions Help Health Systems Address Proposed Mandatory CMS Plan for Episode Payment Models

WEST CHESTER, PA – August 3, 2016 – The Johnson & Johnson Medical Devices Companies are helping health systems across the US achieve better outcomes, efficiencies and higher patient satisfaction through its proven DePuy Synthes Geriatric Fracture Program. DePuy Synthes pioneered the Geriatric Fracture Program for the past decade, and now, it has the potential to assist hospitals to address the Centers for Medicare & Medicaid Services (CMS) newly proposed mandatory coordinated care/episode payment programs.


Codman Neuro Announces Exclusive Distribution Agreement with InNeuroCo, Inc.

BOSTON – JULY 25, 2016 – Codman Neuro*, part of DePuy Synthes Companies of Johnson & Johnson, has entered into an agreement with InNeuroCo, Inc. for exclusive U.S. and European distribution rights for intermediate catheters that enable minimally invasive treatment of hemorrhagic stroke. The announcement was made here at the Society of NeuroInterventional Surgery (SNIS) 13th Annual Meeting.


DePuy Synthes Announces Agreement with Materialise for 3D-Printed Titanium Cranio-Facial Implants

Solothurn, 19 July 2016 – In a development that further underscores ways in which medical devices are being personalized for individual patients, DePuy Synthes, part of the Johnson & Johnson family of companies, announced an agreement with Materialise, a leader in 3D printing, to offer TRUMATCH® titanium 3D-printed implants for use in facial and skull disorders.


New Hand System From DePuy Synthes Companies Designed to Address Patient and Surgeon Needs Through Innovation and Versatility

West Chester, PA – (July 19, 2016) – Today DePuy Synthes Trauma* announced the launch of the Variable Angle Locking Hand System, a comprehensive and versatile system of anatomically contoured and low-profile plates to treat hand fractures and correct deformities. The system features the company’s proprietary Variable Angle Locking technology.


DePuy Synthes Companies Announces Acquisition of BioMedical Enterprises, Inc., A Leader in Small Bone Fixation

WEST CHESTER, Pa. – May 9, 2016 – DePuy Orthopaedics, Inc., part of the DePuy Synthes Companies of Johnson & Johnson, announced today that it has acquired privately-held BioMedical Enterprises, Inc. (BME), a leading manufacturer of Nitinol orthopaedic implants for small bone fixation. The implants are used to treat bunions, hammertoes and other foot and ankle deformities, as well as hand and wrist deformities. The BME acquisition reinforces Johnson & Johnson Medical Devices focus on accelerating meaningful innovation and strengthening DePuy Synthes’ portfolio for elective extremity procedures - providing a more complete solution for foot and ankle and hand and wrist specialists.



Raynham, MA -- March 9, 2016 --DePuy Synthes Companies of Johnson & Johnson, a global leader in orthopaedic and neurological solutions, today announced its manufacturing facility in Raynham, MA has been named a recipient of IndustryWeek's 2015 North America Best Plants Award.

Results per page: 
Back To Top